IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that an overview of the Company’s business strategy will be given at the 23rd Annual ROTH OC Growth Stock Conference, being held at the Ritz-Carlton hotel in Laguna Niguel, California. The Spectrum Pharmaceuticals presentation is at 3:30pm Pacific Time on Monday, March 14, 2011.
